medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2011, Número 1

<< Anterior Siguiente >>

Rev Invest Clin 2011; 63 (1)


Medicina del Dormir: Desarrollo, contribuciones y perspectivas. Reporte del grupo de trabajo en Medicina del Dormir

De-La-Llata-Romero M, Castorena-Maldonado A, Corsi-Cabrera M, Díaz M, Haro-Valencia R, Jiménez-Genchi A, Meza-Vargas MS, Pérez-Padilla R, Próspero-García Ó, Reyes-Zúñiga M, Torre-Bouscoulet L, Valencia-Flores M, Velázquez-Moctezuma J

Idioma: Español
Referencias bibliográficas: 84
Paginas: 90-99
Archivo PDF: 79.51 Kb.


RESUMEN

Dormir, es un proceso biológico básico que influye sobre todas las funciones del cuerpo e interactúa de manera bidireccional con todos los aparatos y sistemas del organismo, de tal forma que los trastornos del sueño se asocian con alteraciones respiratorias, neurológicas, cardiovasculares, endocrinas, inmunológicas, etc., y viceversa. La complejidad de los mecanismos reguladores del sueño y la variedad de sus trastornos, conjuntamente con las evidencias clínicas acumuladas en las últimas décadas, han dado lugar al nacimiento de una rama nueva de la medicina: la Medicina del Dormir, con trastornos intrínsecos bien definidos. La privación o fragmentación del sueño inducidas por los cambios en la dinámica social y laboral, o la presencia de trastornos intrínsecos del sueño, producen efectos nocivos a corto y largo plazo en individuos de todas las edades; los más importantes son el alto riesgo de sufrir accidentes vehiculares y laborales, además de presentar daño cardiovascular, deterioro cognitivo, obesidad y diabetes mellitus, entre otros. Las clínicas y laboratorios de sueño en México han hecho contribuciones importantes en el ámbitos básico y clínico, para el diagnóstico y tratamiento de trastornos del sueño; no obstante, sin una política de salud específica se se- tratamienguirán destinando recursos sólo a la atención a sus efectos y no a la prevención, lo cual hará que las repercusiones sobre la economía y calidad de vida de los pacientes con trastornos del sueño sean mucho mayores que en los países desarrollados. Es necesario construir un programa de atención que incorpore la Medicina del Dormir en las prioridades de atención médica de las instituciones nacionales de salud a todos los niveles. Se ofrecen soluciones y guías para optimizar el logro de metas propuestas y para aumentar la eficiencia y efectividad de los recursos aplicados en este nuevo campo de la medicina.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Berger H. Über das Elektrenkephalogramm des Menschen. Arch Psychiatr 1929; 87: 527-70.

  2. Bootzin RR. Stimulus control treatment for Insomnia. Proceedings, 80th Annual Convention, APA 1972: 395-6.

  3. Spielman AJ, Saskin P, Thorpy MJ. Treatment of chronic insomnia by restriction of time in bed. Sleep 1987; 10: 45-56.

  4. Bickelmann AG, Burwell CS, Robin ED, Whaley RD. Extreme obesity associated with alveolar hypoventilation; a Pickwickian syndrome. 1956; 21: 811-18.

  5. Gastaut H, Tassinari CA, Duron B. Polygraphic study of the episodic diurnal and nocturnal (hypnic and respiratory) manifestations of the Pickwickian syndrome. Brain Res 1965; 2: 167-86.

  6. Kuhlo W, Doll E, Franck MC. Successful management of Pickwickian syndrome using long-term tracheostomy [in German]. Dtsch Med Wochenschr 1969; 94: 1286-90.

  7. Fujita S, Conway W, Zorick F, Roth T. Surgical correction of anatomic abnormalities in obstructive sleep apnea syndrome: uvulopalatopharyngoplasty. Otolaryngol Head Neck Surg 1981; 89: 923-34.

  8. Sullivan CE, Issa FG, Berthon-Jones M, et al. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1981; 1(8225): 862-5.

  9. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community- based study. Sleep Heart Health Study. JAMA, 2000; 283: 1829-36.

  10. Tassone F, Lanfranco F, Gianotti L, et al. Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variables. Clin Endocrinol 2003; 59: 374-79.

  11. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002; 165: 670-6.

  12. Tasali E, Ip MSM. Obstructive sleep apnea and metabolic syndrome alterations in glucose metabolism and inflammation. Proc Am Thorac 2008; 5: 207-17.

  13. McDaid C, Griffin SC, et al. A systematic review of continuous positive airway pressure for obstructive sleep apnoea-hypopnoea syndrome. Sleep Med Rev 2009; 13(6): 427-36.

  14. Valencia-Flores M, Reséndiz M, Castaño VA, Santiago V, Campos RM, Sandino S, et al. Objective and subjective sleep disturbances in patients with Systemic Lupus Erythematosus. Arthritis & Rheumatism 1999; 42(10): 2189-93.

  15. Valencia-Flores M, Cardiel MH, Santiago V, Reséndiz M, Castaño VA, Negrete O, Rosenberg C, et al. Prevalence and factors associated with fibromyalgia in Mexican patients with systemic lupus erythematosus. Lupus 2004; 13: 4-10.

  16. Abad VC, Sarinas PSA, Guilleminaultc C. Sleep and rheumatologic disorders. Sleep Med Rev 2008; 12: 211-28.

  17. Sukegawa M, Noda A, Soga T, et al. Comparison of sleep-disordered breathing and heart rate variability between hemodialysis and non-hemodialysis days in hemodialysis patients. Nagova J Med 2008; 70: 83-8.

  18. Mechtcheriakov S, Graziadei IW, Kugener A, et al. Multidimensional assessment of neuro-psychiatric symptoms in patients with low-grade hepatic encephalopathy: A clinical rating scale. World J Gastroenterol 2005; 11: 5893-98.

  19. Wiltfang J, Nolte W, Weifienborn K, Komhuber J, Ruther E. Psychiatric aspects of portal-systemic encephalopathy. Metabol Brain Dis 1998; 13: 379-89.

  20. Spahr L, Coeytaux A, Giostra E, Hadengue A, Andoni JM. Histamine H1 blocker hydroxyzine improves sleep in patients with cirrhosis and minimal hepatic encephalopathy: A randomized controlled pilot trial. Am J Gastroenterol 2007; 102: 744-53.

  21. Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ, Comparative risk assessment collaborating group. Selected major risk factors and global and regional burden of disease. Lancet 2002; 360: 1347-60.

  22. Valencia-Flores M, Orea A, Castaño VA, Reséndiz M, Rosales M, Rebollar V, Santiago V, et al. Prevalence of sleep apnea and electrocardiographic disturbances in morbidly obese patients. Obesity Res 2000;8(3):262-69.

  23. Jubber AS. Respiratory complications of obesity. Int J Clin Pract 2004; 58: 573-80.

  24. Valencia-Flores M, Rebollar V, Santiago V, Orea A, Rodríguez C, Reséndiz M, Castaño A, et al. Prevalence of pulmonary hypertension and its association with respiratory disturbances in obese patients living at moderately high altitude. Int J Obesity 2004; 28: 1174-80.

  25. Pedroza Granados J, Valencia-Flores M, Ramírez Morales A, Castaño Meneses A, Fong Ponce B, Santiago Ayala V, Reséndiz García M. Alteraciones en la respiración durante el sueño en el paciente obeso. En: Valencia-Flores M, Salín-Pascual R, Pérez- Padilla R, Meza S (Eds.). Trastornos del Dormir. 2a Ed. México, D.F.: McGraw-Hill Interamericana; 2009: 471-86.

  26. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002; 6: 97-111.

  27. Weissman MM, Bland RC, Canino GJ, et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996; 276: 293-99.

  28. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders: An opportunity for prevention? JAMA 1989; 262: 1479-84.

  29. Klink M, Quan SF. Prevalence of reported sleep disturbances in a general population and their relationship to obstructive airways diseases. Chest 1987; 91: 540-6.

  30. Ohayon MM, Caulet M, Guilleminault C. Complaints about nocturnal sleep: how a general population perceives its sleep, and how this relates to complaints of insomnia. Sleep 1997; 20: 715-23.

  31. Gisalsson T, Almqvist M. Somatic diseases and sleep complaints: an epidemiological study of 3201 Swedish men. Acta Med Scand 1987; 221: 475-81.

  32. Scwartz S, McDowell Anderson W, Cole SR, Cornoni-Huntley J, Hays JC, Blazer D. Insomnia and heart disease: a review of epidemiologic studies. J Psychosom Res 1999; 47: 313-33.

  33. Ohayon M. From wakefulness to excessive sleepiness: what we know and still need to know. Sleep Med Rev 2008; 12: 129-41.

  34. Hublin C, Kaprio J, Partinen M, Heikkila K, Koskenvuo M. Daytime sleepiness in an adult, Finnish population. J Intern Med 1996; 239: 417-23.

  35. Rohers T, Carskadon MA, Dement WC, Roth T. Daytime sleepiness and alertness. In: Kryger M, Roth T, Dement W (Eds.). Principles and Practice of Sleep Medicine. Philadelphia: Elsevier Saunders; 2005, p. 39-50.

  36. Breslau N, Roth T, Rosenthal L, Andreski P. Daytime sleepiness: An epidemiological study of young adults. Am J Public Health 1997; 87: 1649-53.

  37. Partinen M, Hublin C. Epidemiology of sleep disorders. In: Kryger M, Roth T, Dement W (Eds.). Principles and Practice of Sleep Medicine. Philadelphia: Elsevier Saunders; 2005: 626-47.

  38. Ferini-Strambi L, Fantini ML, Castronovo C. Epidemiology of obstructive sleep apnea syndrome. Minerva Med 2004; 95: 187-202.

  39. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea. Am J Respir Crit Care Med 2002; 165: 1217-39.

  40. Lindberg E, Gislason T. Epidemiology of sleep-related obstructive breathing. Sleep Med Rev 2000; 4: 411-33.

  41. Torre-Bouscoulet L, Meza-Vargas MS, Castorena-Maldonado A, Pérez-Padilla R. Riesgo cardiovascular en adultos con síndrome de apnea obstructiva del sueño. A 25 años de los primeros estudios de asociación. Gac Méd Méx 2008; 144: 323-32.

  42. Liu SA, Liu CY. Prevalence of snoring in Taichung area: an epidemiological study. J Chin Med Assoc 2004; 67: 32-36.

  43. Enright PL, Newman AB, Wahl PW, Manolio TA, Haponik EF, Boyle PJ. Prevalence and correlates of snoring and observed apneas in 5201 older adults. Sleep 1996; 19(7): 531-38.

  44. Pressman M. Factors that predispose, prime and precipitate NREM parasomnias in adults. Clinical and forensic implications. Sleep Med Rev 2007; 11: 5-30.

  45. Iranzo A, Santamaria J, Tolosa E. The clinical and pathophysiological relevance of REM sleep behavior disorder in neurodegenerative diseases. Sleep Med Rev 2009; 13: 385-401.

  46. Ohayon M, Zulley J, Guilleminault C, Smirne S. Prevalence and pathologic associations of sleep paralysis in the general population. Neurology 1999; 52: 1194-200.

  47. Winkelman JW, Finn L, Young T. Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med 2006; 7: 545-52.

  48. Karroum E, Konofal E, Arnulf I. Restless-legs syndrome. Rev Neurol 2008; 164(8-9): 701-21.

  49. Vaca F. National Highway Traffic Safety Administration (NHTSA) notes. Drowsy driving. Ann Emerg Med 2005; 45(4): 433-6.

  50. Vgontzas AN, Liao D, Bixler EO, Chrousos GP, Vela-Bueno A. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep 2009; 32(4): 491-7.

  51. Bradley TD, Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 2009; 373(9657): 82-93.

  52. Lim J, Dinges DF. Sleep deprivation and vigilant attention. Ann N Y Acad Sci 2008; 1129: 305-22.

  53. Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004; 141(11): 846-50.

  54. Botros N, Concato J, Mohsenin V, Selim B, Doctor K, Yaggi HK. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med 2009; 122(12): 1122-7.

  55. Beihl DA, Liese AD, Haffner SM. Sleep duration as a risk factor for incident type 2 diabetes in a multiethnic cohort. Ann Epidemiol 2009; 19(5): 351-7.

  56. Edinger JD, Means MK. Overview of insomnia: Definitions, epidemiology, differential diagnosis, and assessment. In: Kryger MH, Roth T, Dement WC (Eds.). Principles and Practice of Sleep Medicine. 4th ed. Philadelphia: Elsevier-Saunders; 2005: 702-13.

  57. NCSDR (National Commission on Sleep Disorders Research). Wake Up America: A National Sleep Alert. Volume II: Working Group Reports. 331-355/30683. Washington, DC: Government Printing Office 1994.

  58. NSF (National Sleep Foundation). 2000. 2000 Omnibus Sleep in America Poll. [Online]. Available: http:// www.sleepfoundation.org/publications/2001poll.html [accessed May 25, 2005].

  59. Bouscoulet LT, Vázquez-García JC, Muiño A, , López MV, de Oca MM, Talamo C, et al, PLATINO Group. Prevalence of sleep related symptoms in four Latin American cities. J Clin Sleep Med 2008; 4(6): 579-85.

  60. Flemons WW, , Kuna ST, , Wheatley J. Access to diagnosis and treatment of patients with suspected sleep apnea. Am J Respir Crit Care Med 2004; 169(6): 668-72.

  61. Aserinsky E, Kleitman N. Regularly occurring periods of eye motility, and concomitant phenomena during sleep. Science 1953; 118(3062): 273-4.

  62. Billiard M. Diagnosis of narcolepsy and idiopathic hypersomnia. An update based on the International classification of sleep disorders. Sleep Med Rev 2007; 11: 377-88.

  63. Frenette E, Kushida CA. Primary hypersomnias of central origin. Semin Neurol 2009; 29: 354-67.

  64. Hughes JR. A review of sleepwalking (somnambulism): the enigma of neurophysiology and polysomnography with differential diagnosis of complex partial seizures. Epilepsy Behav 2007; 11: 483-91.

  65. Kotagal S. Parasomnias of childhood. Curr Opin Pediatr 2008; 20: 659-65.

  66. Szelenberger W, Niemcewicz S, Dabrowska AJ. Sleepwalking and night terrors: psychopathological and psychophysiological correlates. Int Rev Psychiatry 2005; 17: 263-70.

  67. Boeve BF. REM sleep behavior disorder: Updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci 2010; 1184: 15-54.

  68. Dempsey JA, Veasey SC, Morgan BJ, O’Donnell CP. Pathophysiology of sleep apnea. Physiol Rev 2010; 90: 797-8.

  69. Mookadam F, Calvin AD, Somers VK. Prevalence and management of central sleep apnea in heart failure patients. Curr Heart Fail Rep 2008; 5: 233-7.

  70. Caylak E. The genetics of sleep disorders in humans: narcolepsy, restless legs syndrome, and obstructive sleep apnea syndrome. Am J Med Genet A 2009; 149A: 2612-26.

  71. Tafti M. Genetic aspects of normal and disturbed sleep. Sleep Med 2009; 10(Suppl. 1): S17-S21.

  72. Kroeger D, de Lecea L. The hypocretins and their role in narcolepsy. CNS Neurol Disord Drug Targets 2009; 8: 271-80.

  73. Benca RM, Peterson MJ. Insomnia and depression. Sleep Med 2008; 9(Suppl. 1): S3-S9.

  74. Manber R, Chambers AS. Insomnia and depression: a multifaceted interplay. Curr Psychiatry Rep 2009; 11: 437-42.

  75. Van Cauter E, Spiegel K, Tasali E, Leproult R. Metabolic consequences of sleep and sleep loss. Sleep Med 2008; 9(Suppl 1): S23-S28.

  76. Jean-Louis G, Zizi F, Clark LT, Brown CD, McFarlane SI. Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components. J Clin Sleep Med 2008; 4(3): 261-72.

  77. Corsi-Cabrera M, Arce C, Ramos J, Lorenzo I, Guevara MA. Time course of reaction time and EEG while performing a vigilance task during total sleep deprivation. Sleep 1996; 19: 563-9.

  78. Roehrs T, Roth T. Sleep, sleepiness, and alcohol use. Alcohol Res Health 2001; 25: 101-9.

  79. Terán-Pérez G, Arana-Lechuga Y, González-Robles RO, Mandujano M, Santana-Miranda R, Esqueda-Leon E, et al. Polysomnographic features in infants with early diagnosis of congenital hypothyroidism. Brain Dev 2010; 32: 332-7.

  80. Haro R, Drucker-Colín R. Effects of long-term administration of nicotine and fluoxetine on sleep in depressed patients. Arch Med Res 2004; 35: 499-506.

  81. Salín-Pascual RJ, Valencia-Flores M, Campos RM, Castaño A, Shiromani PJ. Caffeine challenge in insomniac patients after total sleep deprivation. Sleep Med 2006; 7: 141-5.

  82. Castorena-Maldonado A, Torre-Bouscoulet L, Meza-Vargas S, Vázquez-García JC, López-Escárcega E, Pérez-Padilla R. Preoperative continuous positive airway pressure compliance in children with obstructive sleep apnea syndrome: assessed by a simplified approach. Int J Pediatr Otorhinolaryngol 2008; 72: 1795-800.

  83. Meza S, Mendez M, Ostrowski M, Younes M. Susceptibility to periodic breathing with assisted ventilation during sleep in normal subjects. J Appl Physiol 1998; 85: 1929-40.

  84. American Academy of Sleep Medicine. International Classification of sleep disorders. 2nd Ed. Diagnostic and coding manual. Westchester, Illinois: American Academy of Sleep Medicine; 2005.




2020     |     www.medigraphic.com